BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2209826)

  • 1. Risk assessment in myelodysplastic syndromes: value of clinical, hematologic and bone marrow histologic findings at presentation.
    Morra E; Lazzarino M; Castello A; Inverardi D; Coci A; Alessandrino EP; Brusamolino E; Bernasconi P; Orlandi E; Bonfichi M
    Eur J Haematol; 1990 Aug; 45(2):94-100. PubMed ID: 2209826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors.
    Ríos A; Cañizo MC; Sanz MA; Vallespí T; Sanz G; Torrabadella M; Gomis F; Ruiz C; San Miguel JF
    Br J Haematol; 1990 May; 75(1):26-33. PubMed ID: 2375920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
    Mangi MH; Mufti GJ
    Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.
    Polychronopoulou S; Panagiotou JP; Kossiva L; Mavrou A; Anagnostou D; Haidas S
    Acta Paediatr; 2004 Aug; 93(8):1015-23. PubMed ID: 15456186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis.
    Tricot G; Vlietinck R; Boogaerts MA; Hendrickx B; De Wolf-Peeters C; Van den Berghe H; Verwilghen RL
    Br J Haematol; 1985 May; 60(1):19-32. PubMed ID: 3859319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes.
    Soligo DA; Oriani A; Annaloro C; Cortelezzi A; Calori R; Pozzoli E; Nosella D; Orazi A; Deliliers GL
    Am J Hematol; 1994 May; 46(1):9-17. PubMed ID: 7514357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, hematological and histomorphological profile of myelodysplastic syndrome.
    Nigam S; Rani S; Singh T; Gupta S; Rakheja D; Gaiha M
    J Assoc Physicians India; 2001 Apr; 49():430-4. PubMed ID: 11762613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.
    Arenillas L; Calvo X; Luño E; Senent L; Alonso E; Ramos F; Ardanaz MT; Pedro C; Tormo M; Marco V; Montoro J; Díez-Campelo M; Brunet S; Arrizabalaga B; Xicoy B; Andreu R; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
    J Clin Oncol; 2016 Sep; 34(27):3284-92. PubMed ID: 27382099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
    Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
    Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The International Prognostic Scoring System for primary myelodysplastic syndrome].
    Sisková M; Dohnalová A; Neuwirtová R; Pĕnicková J; Karban J; Cmunt E
    Sb Lek; 2002; 103(3):333-8. PubMed ID: 12688177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic characteristics of 164 patients with myelodysplastic syndromes.
    Reza S; Dar S; Andric T; Qawi H; Mundle S; Shetty V; Venugopal P; Ali I; Lisak L; Raza A
    Leuk Lymphoma; 1999 Apr; 33(3-4):281-7. PubMed ID: 10221507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients.
    Maschek H; Gutzmer R; Choritz H; Georgii A
    Eur J Haematol; 1994 Nov; 53(5):280-7. PubMed ID: 7813708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the prognostic implication of morphology, histology, and karyotype in primary myelodysplastic syndromes.
    Verhoef G; De Wolf-Peeters C; Kerim S; Van De Broeck J; Mecucci C; Van den Berghe H; Boogaerts M
    Hematol Pathol; 1991; 5(4):163-75. PubMed ID: 1794966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tryptase measurements in patients with myelodysplastic syndromes.
    Sperr WR; Stehberger B; Wimazal F; Baghestanian M; Schwartz LB; Kundi M; Semper H; Jordan JH; Chott A; Drach J; Jäger U; Geissler K; Greschniok A; Horny HP; Lechner K; Valent P
    Leuk Lymphoma; 2002 May; 43(5):1097-105. PubMed ID: 12148892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
    Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the haematologic spectrum of myelodysplastic syndrome.
    Kini J; Khadilkar UN; Dayal JP
    Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.